James L. Zehnder, M.D.
Academic Appointments
- Professor - Med Center Line, Pathology
- Member, Stanford Cancer Institute
- Professor - Med Center Line, Medicine - Hematology
Key Documents
Contact Information
-
Clinical Offices
Hematology Clinic Cancer Center 875 Blake Wilbur Dr Clinic C H1507 Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 498-5030Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 723-9232Alternate Contact Angie Banez Administrative Assistant Email Tel Work 6-8002Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Hematology
- Hematology
- Pathology
- Pathology and Laboratory Medicine
Administrative Appointments
- Attending Physician, Hematology Service, Stanford Hospital (1995 - present)
- Director, Coagulation and Molecular Pathology Laboratories, Stanford Hospital (1995 - present)
Professional Education
| Fellowship: | Stanford University CA (1993) |
| Residency: | Stanford University CA (1988) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1987) |
| Internship: | Stanford University School of Medicine CA (1985) |
| Medical Education: | Tufts University MA (1984) |
Scientific Focus
Current Research Interests
Our laboratory focuses on translational research in 2 main areas - molecular evaluation of patients with hematolymphoid malignancy, and molecular and biochemical characterization of disorders of thrombosis and hemostasis.
Clinical Trials
- Integrated Whole-Genome Analysis of Hematologic Disorders Recruiting
- A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma from Both Endemic and Non-Endemic Patient Populations Recruiting
- Evaluation of Pathwork Tissue of Origin (TOO) test for human malignancies Completed
- Phase II Fludarabine, Cytoxan and FCCAM in Untreated B-Cell Chronic Lymphocytic Leukemia Completed
- Phase II Temozolomide in Acute Myeloid Leukemia Patient Age >= 60 Yrs & Poor Risk/Refractory Disease Completed
Publications
- Aggressive EBV-associated Lymphoproliferative Disorder: A Prodrome to Diffuse Large B-cell Lymphoma? Appl Immunohistochem Mol Morphol. 2012; (3): 325-30
- Controversies in heparin monitoring. Am J Hematol. 2012
- Prophylactic rituximab after allogeneic transplantation decreases B cell alloimmunity with low chronic GVHD incidence. Blood. 2012
- Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia. Am J Hematol. 2012; (1): 45-50
- A novel splice donor mutation in the thrombopoietin gene leads to exon 2 skipping in a Filipino family with hereditary thrombocythemia. Blood. 2011; (26): 6988-90
Help